Compare STN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STN | RGC |
|---|---|---|
| Founded | 1954 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.5B |
| IPO Year | 2005 | 2020 |
| Metric | STN | RGC |
|---|---|---|
| Price | $86.91 | $29.85 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $175.00 | N/A |
| AVG Volume (30 Days) | ★ 190.0K | 153.8K |
| Earning Date | 05-13-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.95 | N/A |
| Revenue Next Year | $6.55 | N/A |
| P/E Ratio | $28.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $77.07 | $9.39 |
| 52 Week High | $114.52 | $950.00 |
| Indicator | STN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.33 | 56.59 |
| Support Level | $85.10 | $12.29 |
| Resistance Level | $96.29 | $36.75 |
| Average True Range (ATR) | 2.07 | 3.89 |
| MACD | 0.04 | 0.77 |
| Stochastic Oscillator | 40.92 | 42.66 |
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.